首页|131I全身显像的异常摄取分析

131I全身显像的异常摄取分析

扫码查看
目的 调查131I全身显像异常摄取的发生情况及分析其影响因素.方法 回顾性分析北京核工业医院自2018年1月1日起至2023年6月30日共2426例患者的131I全身显像,总结异常摄取的发生概率及各个部位发生假阳性图像的类型.结果 发现异常摄取总共405例,其中生理性摄取共258例,放射性滞留共95例,非肿瘤性病理学摄取共4例,放射性污染48例.发生在头部72例,在胸部143例,在腹盆部143例,在四肢32例.结论 异常摄取在131I全身显像中的发生率很高,可以出现在身体的各个部位,了解131I全身显像异常摄取的部位及原因,在出现异常摄取时,应结合临床病史及实验室指标综合判断,避免错误解读,可以有效指导患者以后的诊疗.同时,也可能意外发现一些未知情况而进行积极处理.
An Analysis of Abnormal Uptake of 131I Whole-Body Scan
Objective To investigate the incidence of abnormal 131I uptake in whole body scan and to analyze its influencing factors.Methods A total of 2 426 patients with 131I whole-body imaging in Beijing Nuclear Industry Hospital from January 1,2018 to June 30,2023 were retrospectively analyzed.The incidence of abnormal 131I uptake and types of false positive images in various locations of the body were summarized.Results A total of 405 cases were found to have abnormal uptake,including 258 cases of physiological uptake,95 cases of radioactive retention,4 cases of non-neoplastic pathological uptake,and 48 cases of radioactive contamination.There were 72 cases in the head,143 cases in the chest,143 cases in the abdomen and pelvis,and 32 cases in the limbs.Conclusion Abnormal uptake of 131I has a high incidence in whole body imaging and can occur in multiple locations of the body.A comprehensive understanding of the location and causes of abnormal uptake of 131I should be combined with clinical history and laboratory indicators to avoid wrong interpretation,which can effectively guide the future diagnosis and treatment of patients.In addition,unknown conditions could be accidentally found and which can be actively handled.

Differentiated thyroid cancer131I whole-body scanSPECT131I

陈凯琳、高洪波、李隆敏、李赟、刘海春、张晓勇、邵玉军、祝夏阳

展开 >

北京核工业医院核素诊疗中心,北京 102413

中核核医疗分子靶向研究分中心,北京 102413

分化型甲状腺癌 131I全身显像 单发光型计算机断层成像 131I

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(2)
  • 15